Photo by Suzy Hazelwood[/caption]
Acetaminophen also known as paracetamol has been one of the most trusted medicines for pain and fever relief for decades. It’s available everywhere from local pharmacies to prescription medicines and often seen as safe.
But new research in 2025 is giving us fresh insight into how this common drug affects liver health, recommended dosage and long-term safety.
Dr. Dobbins, PharmD[/caption]
MedicalResearch.com Interview with:
Duncan Dobbins, PharmD, MHI
Geisinger College of Health Sciences
Scranton, Pennsylvania
MedicalResearch.com: What prompted this commentary, and what did you find?
Response: In theory, there could be a drug interaction between immunotherapy and medical cannabis. A small (N=102) observational report from Israel appeared to find that immunotherapies worked much less well in cancer patients who also used medical cannabis.1 However, a follow up report2 took about two weeks and involved manually rechecking the math and data-analysis. Several discrepancies emerged between the methods and results. Two-tailed tests were listed in the methods yet one-tailed p values appeared in the results. Arithmetic errors, some traceable to unconventional “floor” rounding, affected key percentages. Multiple p values in Table 1 (21 out of 22) could not be reproduced with the stated tests. Finally, smoking status, a key confound, was not reported. Taken together, these issues complicate interpretation and highlight how small computational slips can cascade into larger inferential uncertainty. For this follow-up report, I was asked, “Do you think AI could have double checked this math?”
1983 marked a turning point for natural medicine in America. German naturopath Dr. Andreas Marx arrived on U.S. shores, carrying with him a treasure trove of European healing wisdom. What he found was a healthcare scene dominated by conventional drugs, with most Americans completely unaware of plant-based alternatives that Europeans had relied on for centuries. Marco Pharma grew from his determination to change this disconnect, gradually introducing American practitioners to biological therapies that would transform how many viewed healing altogether.
Dr. McDonald[/caption]
Emily G. McDonald MD MSc (Epi) FRCPC
Scientist | Research Institute of the McGill University Health Centre
Associate Professor of Medicine | General Internal Medicine | McGill University Health Centre
Associate Chair of Quality and Safety | Department of Medicine | McGill University
Director | Canadian Medication Appropriateness and Deprescribing Network
Centre for Outcomes Research and Evaluation (CORE)
Montreal, QC
https://www.medsafer.org/
https://www.deprescribingnetwork.ca/
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Polypharmacy (taking multiple medications) is common among older adults and can lead to serious side effects like memory problems, falls, fractures, and hospitalization. Deprescribing (the process of stopping some medications that may no longer be beneficial or where the harms outweigh the benefits) is a great solution. This study found that an electronic tool to support prescribers increased deprescribing more than 3 times compared to usual care without the software support.
Photo by Tima Miroshnichenko[/caption]
Key Takeaways:
Photo by Catarina Sousa[/caption]
Dr. Binshtok[/caption]
MedicalResearch.com Interview with:
Prof. Alexander Binshtok PhD
Cecile and Seymour Alpert Professor in Pain Research
Hebrew University’s Faculty of Medicine and Center for Brain Sciences (ELSC)
MedicalResearch.com: What is the background for this study?
Response: Paracetamol (also known as acetaminophen) is one of the world’s most commonly used pain relievers and fever reducers, yet for decades, its precise biological mechanism has remained something of a mystery. Traditionally, scientists believed its analgesic effect stemmed from central nervous system activity—specifically through the action of its metabolite, AM404, on cannabinoid and TRPV1 receptors in the brain.
Image source: Unsplash[/caption]
Biostatistics serves as the backbone of clinical research, converting raw data into meaningful insights that inform medical decision-making. Its methods guide every phase of a study—from how it's designed to how the results are evaluated—ensuring that findings are not only accurate but also relevant to real-world healthcare.
As noted by Busuyi Agbetunsin, this scientific field contributes to the credibility of clinical trials, supports regulatory approvals, and strengthens the foundation of evidence-based medicine. Its influence stretches across drug development, disease prevention, and health policy, making it a crucial tool in the advancement of modern medicine.
Running a medicine distribution center isn’t just about moving boxes from point A to point B. You’re dealing with products that save lives, so there’s no room for guesswork.
Every pill, vial, and package needs to be handled with care, tracked precisely, and delivered fast. You’ve got to think like a health worker, a warehouse manager, and a logistics expert—all at once.
If you mess up, people don’t get the meds they need. But when you do it right, you become a silent hero in the healthcare chain.
In this article, you’ll find smart, practical ways to run a distribution center that actually works—keeping meds safe, fresh, and on time, every time.
Michelle Leman/Pexels[/caption]
Keeping patients on track with their medication during clinical trials is extremely important. If they don’t follow the plan, it can throw off results, slow down new treatments, and even put their health at risk. Healthcare providers must be proactive with medication adherence solutions to make sure patients take their meds as prescribed, keeping trials on schedule and producing reliable data.
Photo by Pilan Filmes[/caption]
In the pharmaceutical industry, precision isn’t just a preference—it’s a necessity. The margin for error in storing temperature-sensitive products such as vaccines, biologics, and critical medications is razor-thin. Even a slight temperature deviation can compromise product integrity, leading to significant financial losses and jeopardizing patient safety. As the global demand for reliable cold storage grows, advanced solutions are becoming more than just beneficial—they’re essential.
This is where cutting-edge ultra-low temperature storage systems come into play, offering unmatched control, safety, and efficiency. Today’s pharmaceutical companies need storage that not only meets but exceeds regulatory expectations, all while supporting operational scalability and sustainability goals.
Image source: Unsplash[/caption]
Psychological research plays a fundamental role in shaping advancements in mental health care and pharmaceutical developments. By studying cognitive and behavioral patterns, researchers uncover crucial insights that drive the creation of effective treatments. Theodore Rex Walrond notes how these findings inform the development of medications that target neurotransmitter imbalances, improving outcomes for individuals with conditions like depression and anxiety.
Supercharge your scientific breakthroughs using Aminos Research & Fladrafinil. Premium-grade compounds for research only—explore Modern Aminos now! ...
Nearly 70% of Phase II and III clinical trials experience delays, averaging an additional 16 months. Every delay in introducing new drugs means longer development cycles, escalating R&D costs and threats to your competitive advantage.
You’re dealing with regulatory checklists and uncertainty, scalability challenges, and supply chain disruptions. All of this unpredictability is not good for your organizational goals or your stress levels.
If only there was a way to navigate low predictability and speed up drug development while also improving outcomes.
The right Contract Development and Manufacturing Organization (CDMO) services can actually grant all three wishes.
CDMO services eliminate these bottlenecks, aligning expertise, infrastructure, and regulatory depth to fast-track commercialization.
| Challenge | How CDMO Services Solve It |
| Project Complexity | Streamline process development from molecule synthesis to clinical trials, ensuring scalability from the start. |
| Regulatory Uncertainty | Maintain compliance with CMC requirements, regional health authorities, and cGMP guidelines for smooth approvals. |
| Supply Chain Bottlenecks | Offer flexible manufacturing capacity, technology transfer support, and risk-mitigated supply chains to prevent disruptions. |
| Lack of Project Visibility | Provide real-time dashboards, milestone tracking, and adaptive workflows for better control and faster iteration. |
| Cost-Related Hurdles | Optimize process efficiency to reduce total cost of ownership without compromising quality or commercial viability. |
Image Source[/caption]
Although each rare disease is uncommon on its own, together, they represent a major global health challenge. With over 7,000 known rare diseases, the global impact is substantial. Currently, around 300 million people worldwide are living with a rare disease.
Unlike more prevalent conditions, rare diseases often receive less research funding, making drug development a lengthy and challenging process. However, recent advancements in antibody drug discovery are transforming this landscape, offering new hope to millions of patients.
Antibody drug discovery is an advanced biotechnology field that utilizes the immune system to develop precise treatments. Scientists identify and isolate specific antibodies capable of binding to disease-causing targets. This approach enables the creation of drugs that directly address the root cause of rare diseases, ensuring more effective and personalized therapies.
In this article, we will explore the transformative impact of antibody drug discovery on rare disease research.
Image Source: Pexels[/caption]
In today's healthcare landscape, personalized treatment is becoming increasingly essential. Patients have unique medical needs that off-the-shelf medications often fail to address. This is where compounding services offer customized pharmaceutical solutions tailored to an individual’s specific requirements. Unlike mass-produced medications, compounded drugs are formulated by specialized pharmacists who create precise dosages, unique formulations, and alternative delivery methods to enhance treatment effectiveness. As the demand for patient-centric care grows, compounded medications are emerging as the future of modern healthcare.
Understanding Compounding Services
Compounding is a pharmaceutical practice allowing licensed pharmacists to modify, mix, or create medications to suit a patient's needs. Unlike traditional pharmacy prescriptions, which rely on standard formulations, compounded medications offer flexibility in dosage, ingredients, and delivery methods. This approach ensures that individuals receive treatments specifically designed for their medical conditions, allergies, and preferences.
Skycell Image[/caption]
SkyCell has emerged as a transformative force in pharmaceutical logistics, offering innovative solutions that ensure the safe, secure, and sustainable transportation of temperature-sensitive medicines. It’s not surprising that the company is an industry leader having introduced hybrid containers to the world. Should you work with them? Find it out in this article
[caption id="attachment_66319" align="aligncenter" width="254"]
Image Source[/caption]
Photo by MART PRODUCTION[/caption]
Drug detoxification is a critical first step in the recovery journey for those struggling with substance use disorders. Whether it's alcohol, opioids, stimulants, or other drugs, the detox process involves the body's effort to remove toxic substances accumulated from drug use. But what exactly happens in the body during detox? What physiological and psychological changes take place? All of these questions are answered by experts at Oasis Detox.
Understanding this process is key to realizing why detox is such a crucial phase in overcoming addiction.
The biopharmaceutical industry has undergone significant transformations in recent years, particularly with the adoption of Quality by Design (QbD) principles. This innovative approach is reshaping the landscape of biopharmaceutical manufacturing by fostering a culture of quality that prioritises proactive measures over reactive solutions. This transformation not only enhances the efficiency of manufacturing processes but also ensures that patients receive safe and effective medications.
Source[/caption]
Security and data protection are priorities in any online transaction, especially for healthcare. This pharmacy’s website is equipped with advanced...
You might have noticed the key details mentioned on medical medicine boxes whenever you pick them up from a pharmacy. Information, precautions, symbols, and brand details mentioned on these boxes are important for individuals who are going to consume these medicines. Custom medicine boxes thus serve as an effective means of conveying the desired insights to the exact audience who is going to benefit from the relevant medicines for curing their specific health issues.
Brands make sure to keep the details mentioned on medical medicine boxes highly relevant and assure the safety of individuals at all times while keeping them informed of the right dose of the medicine they are going to consume.
This post explores how important are these custom packaging solutions for your pharmaceutical brand and what are the key features of medical medicine boxes.
Dr. Suda[/caption]
Katie J. Suda, PharmD, M.S., FCCP
Professor of medicine with tenure
Associate Director, Center for Pharmaceutical Policy and Prescribing
University of Pittsburgh School of Medicine
MedicalResearch.com: What is the background for this study?
Response: Our pharmaceutical supply chain is global where the manufacturing process for one drug may occur in multiple countries. Sometimes there are breakdowns in the pharmaceutical supply chain which may threaten access to medicines. Breakdowns in the supply chain occur for medicines manufactured in the U.S. and by international partners. While breakdowns in the supply chain occur for hundreds of drugs each year, not all result in a decrease in available supply (a “drug shortage”) because of action taken by manufacturers, pharmacies and drug regulators (e.g., the U.S. Food and Drug Administration [FDA]).
Drug shortages are a critical concern to public health as pharmacies, clinicians, and patients struggle to identify safe and effective alternatives. In addition, drug shortages have been associated with adverse patient outcomes and medication safety events. Recently, drug shortages have gotten worse with shortages occurring with increasing frequency and lasting longer. There has also been a shift in the types of medicines in shortage from drugs primarily used in hospitals, such as injectables, to oral medicines frequently used to manage outpatient conditions.
Countries have different regulatory authority and policy which may impact how drug supply chain breakdowns result in drug shortages. We wanted to know if there are differences between the U.S. and Canada in the frequency that national drug shortages occur after supply chain breakdowns are reported in both countries. Canada is a good comparator to the U.S. because Canada has similar drug regulatory standards and manufacturing inspections. Prescription drug coverage is also similar for the two countries where half of prescriptions are reimbursed through public insurance and half through private insurance and out-of-pocket.
Source[/caption]
Access to affordable insulin remains a challenge for millions of people living with diabetes around the world, particularly in middle-income countries. To bridge this gap, platforms are emerging that connect patients with high-quality insulin at reduced prices. For individuals struggling to afford their life-saving medication, these services offer a convenient and affordable solution, making a significant impact on global health.
Integrated within a hospital’s Computerized Physician Order Entry system or not, pharmacy management systems play a critical role in healthcare...
Source[/caption]